Ellson Ye-Shyon Chen

Title: Ellson Ye-Shyon Chen: Innovator in Asthma Research

Introduction

Ellson Ye-Shyon Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of genetics, particularly in relation to asthma susceptibility. His work focuses on the Protein-Tyrosine Phosphatase Receptor-type Delta (PTPRD) gene, which is linked to asthma and infection susceptibility.

Latest Patents

Ellson Ye-Shyon Chen holds a patent titled "Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to asthma." This patent outlines a method for detecting the asthma-associated gene, predicting the occurrence of asthma, identifying asthma-associated alleles in the PTPRD gene, and screening PTPRD for drugs useful in asthma treatment. Additionally, it includes antibodies specific for PTPRD variants and their use in diagnostic assays. He has 1 patent to his name.

Career Highlights

Ellson is currently associated with Vita Genomics, Inc., where he continues to advance research in genetic diagnostics and therapeutic development. His innovative approach has positioned him as a key figure in the field of asthma research.

Collaborations

Ellson collaborates with Shih Hsin Wu, who is also involved in research related to asthma and genetic studies. Their partnership enhances the potential for groundbreaking discoveries in this critical area of health.

Conclusion

Ellson Ye-Shyon Chen's contributions to asthma research through his innovative patent and collaboration with colleagues highlight the importance of genetic studies in understanding and treating respiratory conditions. His work continues to pave the way for advancements in medical diagnostics and therapies.